Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy.
- 1 June 1978
- journal article
- Vol. 3, 16-9
Abstract
The nitro radiosensitizers, metronidazole and misonidazole, have been shown to react rapidly with the sulphydryl compounds cysteine and cysteamine in the presence of ferrous ions. Similar reactions occur in the presence of copper ions but these are much slower. The initial interactions of the drugs and of oxygen with an iron-cysteine complex are extremely rapid: in the case of oxygen reaction half-lives of 27 ms have been measured. Misonidazole also reacts rapidly with glutathione in the presence of ferrous ions and is subsequently reduced: metronidazole is reduced only slowly if at all. These reactions, which have been found to be inhibited by high concentrations of zince ions, are discussed in the light of the known radiosensitizing and chemotherapeutic efficiencies of the nitro drugs and the side effect of peripheral neuropathy sometimes observed during their clinical use.This publication has 7 references indexed in Scilit:
- Radiotherapy pilot trials with sensitizers of hypoxic cells: metronidazole in supratentorial glioblastomasThe British Journal of Radiology, 1977
- Radiosensitization of Tumor CellsNew England Journal of Medicine, 1976
- Metronidazole (Flagyl): iron catalysed reaction with sulphydryl groups and tumour radiosensitisationNature, 1975
- Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to X raysThe British Journal of Radiology, 1973
- Radiosensitization of anoxic cells by metronidazoleThe British Journal of Radiology, 1973
- Radiosensitization of Bacterial and Mammalian Cells by Substituted GlyoxalsNature, 1967
- Hydrated electrons and radiobiological sensitisationBiochemical and Biophysical Research Communications, 1963